Tags: BreastCancer, Genetics
Dr. Mehra Golshan and Dr. Yasuaki Sagara led a study that showed surgery for a very early type of breast cancer does not significantly improve outcomes for patients.
Dr. Harold Burstein commented on the increase in women
opting to undergo preventive bilateral mastectomies.
Dr. Judy Garber discussed breast cancer among men and the lack of awareness despite a surge in news surrounding the BRCA gene.
Dr. Mehra Golshan led a study that shows many patients are
opting for a mastectomy despite the high success rates a lumpectomy can offer.
Dr. Rachel Freedman led a study showing black and Hispanic women with breast cancer were less likely to pick their surgeon and the hospital for treatment based on reputation compared with white women.
Dr. Ann Partridge helped launch a new app, called ResearchKit, part of Apple's mobile health program. The app will allow researchers to access data from breast cancer survivors to provide improved post-treatment quality of life.
Dr. Harold Burstein commented on a new study that found among women with operable hormone-receptor-negative breast cancer, who were given goserelin (Zoladex) in addition to chemotherapy, had lower rates of ovarian failure and higher rates of pregnancy compared with patients treated with chemotherapy alone.
WCVB-TV reporter and breast cancer survivor Kelley Tuthill is pregnant, and her oncologist, Dr. Ann Partridge, assured her studies show there is no link between pregnancy after successful treatment and recurrence.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: